NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SYNthesis BioVentures

SYNthesis BioVentures

Parkvillesynthesisbioventures.com

Overview

SYNthesis BioVentures is a venture capital fund that invests in early-stage therapeutics, including small molecule therapeutics, biologics, and cell and gene therapies.

Year Founded

2022

Portfolio Companies

2

Investments

SYNthesis BioVentures investments
CompanyDateStageLead
Skin2NeuronOct 2024VC RoundLead
Aculeus TherapeuticsSep 2023SAFELead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersParkville
Year Founded2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.